INS and type 2 diabetes mellitus: In the current study, metformin showed successful antidiabetic activity in rats; metformin is recognized for its efficacy in reducing blood glucose levels in individuals with type 2 diabetes; this is mainly achieved by suppressing hepatic gluconeogenesis and enhancing peripheral insulin sensitivity [37,38].